Loading...
Back to narrative

Update shared on06 Sep 2025

Fair value Increased 4.00%
AnalystConsensusTarget's Fair Value
US$238.46
14.2% undervalued intrinsic discount
06 Sep
US$204.68
Loading
1Y
470.9%
7D
1.5%

Centrus Energy’s fair value target has increased to $238.46 as analysts cite strengthened industry position from major partnership agreements, extended federal contracts, and strategic importance in advanced nuclear supply chains—despite minor revenue misses—amid strong policy and investor support for domestic nuclear enrichment.


Analyst Commentary


  • Bullish analysts highlight Centrus' signing of an MOU with major Korean nuclear and industrial partners as a strong signal of industry confidence in its enrichment technology and role in the domestic nuclear fuel supply chain.
  • Improved price targets are supported by U.S. Department of Energy contract extensions, with further optionality for continued production, cementing Centrus’ positioning amid rising federal support and policy backing for domestic enrichment capabilities.
  • Centrus’ partnership and supply agreement with TerraPower, along with significant private capital inflows into advanced nuclear projects (including from AI-focused investors), reinforce its strategic value as a key HALEU supplier for both commercial and national security applications.
  • Analysts see Centrus uniquely positioned as the only publicly traded pure-play nuclear enrichment company, possessing the technology, footprint, and credibility to capture a leading role in the supply chain rebuild for both existing and new nuclear reactors.
  • Despite quarterly revenue slightly lagging estimates, the company’s EPS performance and reduced dilution risk driven by share price appreciation are cited as positives; overall industry tailwinds, including major policy support and increased investor focus on scalable, carbon-free energy, drive bullish sentiment.

What's in the News


  • Centrus Energy signed a non-binding MOU with Korea Hydro & Nuclear Power and POSCO International to explore private investment and support expansion of its uranium enrichment plant in Ohio, contingent on securing federal funding.
  • Centrus and KHNP increased the supply volume of Low-Enriched Uranium under an existing contract, with the commitment subject to receiving U.S. Department of Energy funding for new capacity.
  • J.P. Morgan Securities LLC and BofA Securities, Inc. have been added as Co-Lead Underwriters for Centrus Energy's $700 million Fixed-Income Offering.
  • Todd Tinelli was appointed Chief Financial Officer, replacing Kevin Harrill, bringing over 20 years of experience in energy industry finance and operations.
  • The U.S. Department of Energy exercised an option to extend Centrus' HALEU production contract through June 2026, with further extension options for up to eight additional years.

Valuation Changes


Summary of Valuation Changes for Centrus Energy

  • The Consensus Analyst Price Target has risen slightly from $229.30 to $238.46.
  • The Consensus Revenue Growth forecasts for Centrus Energy has significantly fallen from 13.6% per annum to 8.6% per annum.
  • The Net Profit Margin for Centrus Energy has significantly risen from 10.96% to 12.14%.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.